DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

8 API Suppliers, 3 USDMF, 2 CEP/COS, 1 JDMF, 3 KDMF, 2 NDC API, 3 Listed Suppliers

8 API Suppliers
3 USDMF
2 CEP/COS
1 JDMF
3 KDMF
2 NDC API
3 Listed Suppliers

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 14 SPI Pharma, 1 DKSH, 2 Faran Shimi Pharmaceutical, 2 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 3 Actylis, 1 Alcedo Pharmachem, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 5 BASF, 2 DFE Pharma, 5 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 1 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 7 Kerry, 10 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 22 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

47 Fillers, Diluents & Binders, 27 Direct Compression, 16 Taste Masking, 15 Film Formers & Plasticizers, 14 Thickeners and Stabilizers, 13 Co-Processed Excipients, 12 Chewable & Orodispersible Aids, 12 Granulation, 11 Lubricants & Glidants, 11 Coating Systems & Additives, 10 Parenteral, 7 Controlled & Modified Release, 5 Disintegrants & Superdisintegrants, 3 Emulsifying Agents, 2 API Stability Enhancers, 2 Solubilizers, 1 Soft Gelatin, 1 Topical, 1 Rheology Modifiers

MARKET PLACE

2 APIs

marketPlace
2 APIs

REF. STANDARDS & IMPURITIES

1 USP

otherSolutions
1 USP

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

115 RELATED EXCIPIENT COMPANIES

210EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Mammol (tn), Bismuth subnitrate (jp17/usp), Chebi:31293, D01642, Q27114265

Molecular Formula

BiH₂N₃O₉

Molecular Weight

397.01 g/mol

InChI Key

HWSISDHAHRVNMT-UHFFFAOYSA-N

1 2D Structure

Bismuth Nitrate

2 Identification

2.1 Computed Descriptors

2.1.1 InChI

InChI=1S/Bi.H2NO3.2NO3/c;3*2-1(3)4/h;1-2H;;/q+3;3*-1

2.1.2 InChI Key

HWSISDHAHRVNMT-UHFFFAOYSA-N

2.1.3 Canonical SMILES

[NH+](O)([O-])O[Bi](O[N+](=O)[O-])O[N+](=O)[O-]

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. Mammol (tn)

2. Bismuth Subnitrate (jp17/usp)

3. Chebi:31293

4. D01642

5. Q27114265

2.3 Create Date

2007-08-23

3 Chemical and Physical Properties

Molecular Formula	BiH₂N₃O₉
Molecular Weight	397.01 g/mol
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	9
Rotatable Bond Count	4
Exact Mass	396.95950 g/mol
Monoisotopic Mass	396.95950 g/mol
Topological Polar Surface Area	161 Å²
Heavy Atom Count	13
Formal Charge	0
Complexity	164
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1